{"id":"https://openalex.org/W2155075889","doi":"https://doi.org/10.1128/aac.46.5.1336-1339.2002","title":"Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro","display_name":"Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro","alternate_titles":[],"publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2155075889","doi":"https://doi.org/10.1128/aac.46.5.1336-1339.2002","mag":"2155075889","pmid":"https://pubmed.ncbi.nlm.nih.gov/11959565","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/127193"},"language":"en","primary_location":{"id":"doi:10.1128/aac.46.5.1336-1339.2002","doi":"https://doi.org/10.1128/aac.46.5.1336-1339.2002","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.46.5.1336-1339.2002","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2155075889"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC127193/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067324604","display_name":"Cecile L. Tremblay","orcid":"https://orcid.org/0000-0002-3440-3436","observed_orcids":["https://orcid.org/0000-0002-3440-3436"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ce\u0301cile L. Tremblay","raw_affiliation_strings":["Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112677174","display_name":"Francoise F. Giguel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Franc\u0327oise Giguel","raw_affiliation_strings":["Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073841219","display_name":"Christopher S. Kollmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Kollmann","raw_affiliation_strings":["Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103165007","display_name":"Yongbiao Guan","orcid":"https://orcid.org/0000-0002-4780-3412","observed_orcids":["https://orcid.org/0000-0002-4780-3412"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongbiao Guan","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026225196","display_name":"Ting\u2010Chao Chou","orcid":"https://orcid.org/0000-0002-3340-1594","observed_orcids":["https://orcid.org/0000-0002-3340-1594"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ting-Chao Chou","raw_affiliation_strings":["Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088229002","display_name":"Bahige M. Baroudy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bahige M. Baroudy","raw_affiliation_strings":["Schering-Plough Research Institute, Kenilworth, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schering-Plough Research Institute, Kenilworth, New Jersey","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012623658","display_name":"Martin Hirsch","orcid":"https://orcid.org/0000-0002-0192-2803","observed_orcids":["https://orcid.org/0000-0002-0192-2803"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Martin S. Hirsch","raw_affiliation_strings":["Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Infectious Diseases Unit, Harvard Medical School, Boston, Massachusetts;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5012623658"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"],"apc_list":null,"apc_paid":null,"fwci":8.4886,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.98237806,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"46","issue":"5","first_page":"1336","last_page":"1339"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr5-antagonist","display_name":"CCR5 antagonist","score":0.9760000109672546},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.902999997138977},{"id":"https://openalex.org/keywords/antiretroviral-drug-interactions","display_name":"antiretroviral drug interactions","score":0.7889999747276306},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6919999718666077},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.8980000019073486},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.9010000228881836},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":1.0},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.9990000128746033},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/indinavir","display_name":"indinavir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/t-20","display_name":"T-20","score":0.8550000190734863},{"id":"https://openalex.org/keywords/hiv-1-fusion-inhibitors","display_name":"HIV-1 fusion inhibitors","score":0.9129999876022339},{"id":"https://openalex.org/keywords/multidrug-resistant-hiv-1","display_name":"multidrug-resistant HIV-1","score":0.8289999961853027},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.8000718355178833},{"id":"https://openalex.org/C37044404","wikidata":"https://www.wikidata.org/wiki/Q5009692","display_name":"CCR5 receptor antagonist","level":5,"score":0.779686689376831},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.7768716812133789},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7223179936408997},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.716055154800415},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.633354902267456},{"id":"https://openalex.org/C2777210460","wikidata":"https://www.wikidata.org/wiki/Q425490","display_name":"Indinavir","level":5,"score":0.6247094869613647},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5991494059562683},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.5954070687294006},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.46320971846580505},{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.45893096923828125},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.44995832443237305},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4474197328090668},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.14164265990257263},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.13681063055992126},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.12041637301445007},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.11390739679336548},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.11142158508300781},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0702277421951294},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.06599733233451843},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06595948338508606},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.0655055046081543},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.052612632513046265},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D003497","descriptor_name":"Cyclic N-Oxides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065100","descriptor_name":"CCR5 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.46.5.1336-1339.2002","doi":"https://doi.org/10.1128/aac.46.5.1336-1339.2002","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.46.5.1336-1339.2002","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmid:11959565","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11959565","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:127193","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC127193/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:127193","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC127193/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8022760065","display_name":"IMMUNE REACTIVITY AND ONCOGENIC VIRUS INFECTION","funder_award_id":"R01CA012464","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W565417519","https://openalex.org/W1582887581","https://openalex.org/W1978444406","https://openalex.org/W1984270093","https://openalex.org/W1995355944","https://openalex.org/W1998859554","https://openalex.org/W2000239378","https://openalex.org/W2000988310","https://openalex.org/W2010521915","https://openalex.org/W2026004788","https://openalex.org/W2027738518","https://openalex.org/W2033757712","https://openalex.org/W2053624248","https://openalex.org/W2069407559","https://openalex.org/W2095886530","https://openalex.org/W2108256128","https://openalex.org/W2114891120","https://openalex.org/W2133315239","https://openalex.org/W2135739941","https://openalex.org/W2149568397","https://openalex.org/W2162258466","https://openalex.org/W2318289184","https://openalex.org/W2318542509","https://openalex.org/W2339219218","https://openalex.org/W4231232411"],"related_works":["https://openalex.org/W2135739941","https://openalex.org/W2145267805","https://openalex.org/W2105607249","https://openalex.org/W2103831221","https://openalex.org/W2031379259","https://openalex.org/W2157024344","https://openalex.org/W2040506780","https://openalex.org/W2317157283","https://openalex.org/W2067087165","https://openalex.org/W2145684699"],"abstract_inverted_index":{"SCH-C":[0,40,86,121,132],"(SCH":[1],"351125)":[2],"is":[3],"a":[4,88,135,144],"small-molecule":[5],"antagonist":[6],"of":[7,39,90,104,146,156],"the":[8,80,100,154],"human":[9],"immunodeficiency":[10],"virus":[11,125],"type":[12],"1(HIV-1)":[13],"coreceptor":[14],"CCR5.":[15],"It":[16],"has":[17],"in":[18,45,139,153],"vitro":[19],"activity":[20],"against":[21,87,98],"R5":[22,91,124],"viruses":[23,101],"with":[24,41,51],"50%":[25],"inhibitory":[26,70],"concentrations":[27,71],"ranging":[28],"from":[29],"1.0":[30],"to":[31,109],"30.9":[32],"nM.":[33],"We":[34,73,94],"have":[35,74],"studied":[36,76],"anti-HIV-1":[37],"interactions":[38,48,78,97],"other":[42],"antiretroviral":[43],"agents":[44],"vitro.":[46],"Synergistic":[47],"were":[49],"seen":[50],"nucleoside":[52],"reverse":[53,60,110],"transcriptase":[54,61,111],"inhibitors":[55,62,66,149],"(zidovudine":[56],"and":[57,64,85,112,122,142],"lamivudine),":[58],"nonnucleoside":[59],"(efavirenz),":[63],"protease":[65,113],"(indinavir)":[67],"at":[68],"all":[69,99],"evaluated.":[72],"also":[75,118],"antiviral":[77],"between":[79,120],"HIV-1":[81,92],"fusion":[82],"inhibitor":[83],"T-20":[84],"panel":[89],"isolates.":[93],"found":[95],"synergistic":[96],"tested,":[102],"some":[103],"which":[105],"harbored":[106],"resistance":[107],"mutations":[108],"inhibitors.":[114],"Anti-HIV-1":[115],"synergy":[116],"was":[117],"observed":[119],"another":[123],"inhibitor,":[126],"aminooxypentane-RANTES.":[127],"These":[128],"findings":[129],"suggest":[130],"that":[131,143],"may":[133,150],"be":[134,151],"useful":[136,152],"anti-HIV":[137],"drug":[138],"combination":[140,145],"regimens":[141],"chemokine":[147],"coreceptor/fusion":[148],"treatment":[155],"multidrug-resistant":[157],"viruses.":[158]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2155075889","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
